v3.26.3
CONVERTIBLE NOTES AND WARRANT LIABILITIES (Tables)
6 Months Ended
Jun. 30, 2026
Convertible Notes And Warrant Liabilities Abstract  
Schedule of Convertible Note and Warrant Liabilities
   Convertible
note
   Warrant
liabilities
 
   $   $ 
         
Balance as of December 31, 2025   -    1,213,340 
Gain on derecognition of warrants repurchased   -    (355,857)
Repurchase of warrant liabilities   -    (857,143)
Issued on March 2, 2026, at fair value   10,573,648    6,544,124 
Fair value changes   (2,640,885)   (4,303,563)
Gain on derecognition of convertible notes on cash settlement   (151,071)     
Gain recognised in other comprehensive income – own credit risk   (1,726)   - 
Settlement in cash   (5,784,573)   - 
Converted or exercised into Class A ordinary shares   (667,528)   (2,223,168)
As of June 30, 2026 – fair value   1,327,865    17,733 
Day 1 difference not yet recognized in profit or loss   (1,313,486)   - 
Balance as of June 30, 2026 (unaudited)   14,379    17,733 
           
Day 1 difference not yet recognized in profit or loss          
Balance as of December 31, 2025   -    - 
Deferred on initial recognition, March 2, 2026   7,176,298    4,441,474 
Amortization of deferred day-one loss from the redemption of the convertible notes   (5,065,446)   - 
Amortization of deferred day-one loss the settlement of the convertible notes   (344,317)   - 
Amortization against the share capital credit on the conversion of the convertible
  notes
   (453,049)   (1,508,856)
Amortization of deferred day-one loss on the warrants exercises   -    (2,932,618)
Balance as of June 30, 2026 (unaudited)   1,313,486    - 
Schedule of Fair Value Measurements Within Level 3

Significant unobservable inputs included expected volatility, expected term, risk-free interest rate, discount rate and assumptions regarding redemption and settlement outcomes. Because these inputs are not directly observable in active markets and involve significant management judgment, the related fair value measurements were classified within Level 3 of the fair value hierarchy under IFRS 13.

 

      As of
June 30,
2026
   As of
June 2,
2026
   As of
April 13,
2026
   As of
March 13,
2026
   As of
March 12,
2026
   As of
March 4,
2026
   As of
March 2,
2026*
 
Valuation Technique     Significant Unobservable Input                            
Black-Scholes option pricing model  Expected volatility   86.1%   -    83.2%   82.1%   81.6%   81.4%   81.1%
   Expected term (years)   4.67    
-
    4.89    4.97    4.97    4.99    5.00 
   Risk-free interest rate   4.2%   -    3.9%   3.9%   3.9%   3.7%   3.6%
Discounted cash flow methodology  Discounted rate   16.6%   15.1%   -    -    -    -    14.7%

 

*March 2, 2026 represents the initial measurement date. The fair value of the instruments was determined upon issuance using the valuation techniques and significant unobservable inputs disclosed above. Subsequent fair value measurements were performed at each conversion date and as of June 30, 2026.